DrugBiological
HPV E6/E7 DNA Vaccine GX-188E clinical trials
Also written GX-188E.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2014
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2014 (1)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 2
Genexine, Inc. (3) · Yonsei University (1) · Seoul St. Mary's Hospital (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses HPV E6/E7 DNA Vaccine GX-188E is read from its arms, and is right about nine times in ten.
Testing it · 5
- Trial of the Combination of GX-188E Vaccination, GX-I7 and Pembrolizumab in Patients With Advanced, Resectable HPV Type 16 and/or 18 Positive Head and Neck CancerActive, not recruitingPhase 2Yonsei UniversityNCT05286060Written as GX-188E, GX-I7, Pembrolizumab
- The Combination of GX-188E Vaccination and Pembrolizumab in Patients With HPV 16 and/or 18+ Advanced Cervical CancerCompletedPhase 1/2Genexine, Inc.NCT03444376Written as GX-188E
- Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial NeoplasiaCompletedPhase 2Genexine, Inc.NCT02139267Written as GX-188E
- Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Plasmid DNA Therapeutic Vaccine(GX-188E)Status unknownPhase 2Genexine, Inc.NCT02596243Written as GX-188E
- Safety and Efficacy of GX-188E Administered Via EP Plus GX-I7 or Imiquimod.Status unknownNot applicableSeoul St. Mary's HospitalNCT03206138Written as GX-188E, GX-I7